What is butorphanol used for?

Indications and Usage, quoted from the label by Hospira, Inc. (ANDA074626). Cross-references to other label sections are left out.

Butorphanol Tartrate Injection is indicated

• as a preoperative or pre-anesthetic medication
• as a supplement to balanced anesthesia
• for the relief of pain during labor, and
• for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.

Limitations of Use:

Because of the risks of addiction, abuse, misuse, overdose, and death, which can occur at any dosage or duration and persist over the course of therapy, reserve opioid analgesics, including butorphanol tartrate, for use in patients for whom alternative treatment options are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain.

Source: DailyMed label, set id 9822ca3f-aee2-46e5-8a96-495400e65d10, version 29, effective October 6, 2026. NDC 0409-1623, one of 4 listings for this product.

Indications and Usage, quoted from the label by Apotex Corp. (ANDA075499). Cross-references to other label sections are left out.

Butorphanol tartrate nasal spray is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.

Limitations of Use:

• Because of the risks of addiction, abuse, misuse, overdose, and death, which can occur at any dosage or duration, and persist over the course of therapy, reserve opioid analgesics, including butorphanol tartrate, for use in patients for whom alternative treatment options are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain.

Source: DailyMed label, set id b8e48063-0b40-ee43-85c1-4ef2de80c404, version 24, effective September 9, 2026. NDC 60505-0813, one of 2 listings for this product.

Indications and Usage, quoted from the label by Hikma Pharmaceuticals USA Inc. (ANDA075824). Cross-references to other label sections are left out.

Butorphanol Tartrate Nasal Spray is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.

Limitations of Use

Because of the risks of addiction, abuse, misuse, overdose, and death, which can occur at any dosage or duration and persist over the course of therapy, reserve opioid analgesics, including Butorphanol Tartrate Nasal Spray, for use in patients for whom alternative treatment options are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain.

Source: DailyMed label, set id 5a50d22e-acbe-4b15-9ed6-70713378408a, version 20, effective November 20, 2025. NDC 0054-3090, one of 1 listing for this product.